Insider Transactions in Q1 2021 at Lumos Pharma, Inc. (LUMO)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2021
|
Richard J Hawkins Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,329
+0.31%
|
-
|
|
Feb 01
2021
|
Eugene P. Kennedy Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
939
+7.6%
|
-
|
|
Feb 01
2021
|
Carl W. Langren Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
939
+7.16%
|
-
|
|
Feb 01
2021
|
Lori D Lawley Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
869
+13.21%
|
-
|
|
Feb 01
2021
|
John C. Mc Kew Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,078
+7.03%
|
-
|
|
Feb 01
2021
|
Bradley J Powers General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
869
+13.81%
|
-
|
|
Jan 08
2021
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
106,512
-4.01%
|
$2,449,776
$23.31 P/Share
|
|
Jan 07
2021
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,172
-0.89%
|
$388,128
$24.7 P/Share
|
|
Jan 06
2021
|
James E Flynn > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
29,039
-1.55%
|
$638,858
$22.55 P/Share
|